Actively Recruiting
Evaluation of the Tornier Perform Reversed MonoPost Device for Shoulder Arthroplasty Safety and Function
Led by Stryker Trauma and Extremities · Updated on 2026-10-23
150
Participants Needed
2
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multi-center, prospective follow-up study to evaluate the safety and effectiveness of the Tornier Perform Reversed MonoPost System, a device used in shoulder arthroplasty. The study focuses on patients with shoulder conditions like rheumatoid arthritis, degenerative joint disease, fractures, and traumatic arthritis who are candidates for or have received shoulder replacement surgery using this device. Participants will receive the commercially available Tornier Perform Reversed MonoPost Glenoid device, which replaces the glenoid part of the shoulder joint as part of a reverse shoulder prosthesis. This device includes options for different types of glenoid baseplates to accommodate various shoulder wear patterns. The study will enroll approximately 150 subjects over one year and follow them for up to two years, collecting imaging such as x-rays or CT scans and clinical data. During the study, participants will be monitored through assessments including shoulder function scores ASES and Constant-Murley, patient satisfaction, range of motion, and safety evaluations like adverse event tracking and revision rates. The main outcome is improvement in shoulder function measured by the ASES score at two years compared to baseline. Data will be collected throughout the follow-up period, and participants will be observed according to the surgeons standard care practices.
CONDITIONS
Brief Title
Tornier Perform™ Reversed Monopost Study
Research Team
M
Monica Fleeman
R
Rebecca Gibson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here